Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care

Introduction Acute lower respiratory infections (ALRIs) are a major contributor to the global infectious disease burden and a common cause of hospitalisation for children under 2 years. We compared clinical severity in children hospitalised with respiratory syncytial virus (RSV), parainfluenza virus...

Full description

Bibliographic Details
Main Authors: Sarna, Minda, Le, H., Taye, Belaynew, Glass, K., Levy, A., Richmond, P., Moore, Hannah
Format: Journal Article
Language:English
Published: 2024
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/97271
_version_ 1848766248391802880
author Sarna, Minda
Le, H.
Taye, Belaynew
Glass, K.
Levy, A.
Richmond, P.
Moore, Hannah
author_facet Sarna, Minda
Le, H.
Taye, Belaynew
Glass, K.
Levy, A.
Richmond, P.
Moore, Hannah
author_sort Sarna, Minda
building Curtin Institutional Repository
collection Online Access
description Introduction Acute lower respiratory infections (ALRIs) are a major contributor to the global infectious disease burden and a common cause of hospitalisation for children under 2 years. We compared clinical severity in children hospitalised with respiratory syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV) and influenza virus (IFV). Methods We used a probabilistically linked population cohort born in Western Australia between 2010 and 2020 and hospitalised before the age of 2 years. Outcomes compared included length of hospital stay (LOS), admission to intensive care unit (ICU), need for respiratory support (RS), complex hospital course (RS, death, ICU admission or LOS >75th percentile), 7-day and 30-day mortality, hospital-in-the-home care, 30-day all-cause and ALRI-specific readmissions and emergency department presentations 14 days prior to hospitalisation. Logistic regression was used for binary outcomes, and negative binomial regression was used for discrete count variables. Incidence rates, time to RS and time to readmissions were calculated using survival analysis techniques. Results The final cohort included 210 997 hospitalised children under 24 months of age for a total of 315 769 admissions. Infants hospitalised before 6 months had the highest rates for all virus-specific hospitalisations, particularly RSV hospitalisations (50.4 per 1000 child-years (95% CI 48.7 to 52.1)). Infants <6 months had higher odds of an ICU admission (adjusted OR (aOR) 2.39, 95% CI 1.36 to 4.19) and RS (aOR 4.68, 95% CI 2.95 to 7.44) and a complex hospital course (aOR 2.69, 95% CI 2.13 to 3.42) with RSV and four times higher hazards of requiring RS earlier (adjusted HR (aHR) 4.06, 95% CI 2.59 to 6.36). An ALRI-coded 30-day readmission was recorded in 10%-24% of virus-specific hospitalisations. Discussion Young infants have a more severe and complex hospital course with RSV hospitalisation compared with hospitalisation with other respiratory viruses and should be prioritised for prevention measures such as the single-dose monoclonal antibody, nirsevimab.
first_indexed 2025-11-14T11:48:08Z
format Journal Article
id curtin-20.500.11937-97271
institution Curtin University Malaysia
institution_category Local University
language eng
last_indexed 2025-11-14T11:48:08Z
publishDate 2024
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-972712025-04-30T02:25:43Z Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care Sarna, Minda Le, H. Taye, Belaynew Glass, K. Levy, A. Richmond, P. Moore, Hannah Clinical Epidemiology Respiratory Infection Humans Infant Respiratory Syncytial Virus Infections Male Female Influenza, Human Metapneumovirus Paramyxoviridae Infections Hospitalization Severity of Illness Index Western Australia Length of Stay Infant, Newborn Australia Child, Preschool Respiratory Tract Infections Respirovirus Infections Humans Metapneumovirus Respiratory Tract Infections Paramyxoviridae Infections Respirovirus Infections Respiratory Syncytial Virus Infections Hospitalization Length of Stay Severity of Illness Index Child, Preschool Infant Infant, Newborn Australia Western Australia Female Male Influenza, Human Introduction Acute lower respiratory infections (ALRIs) are a major contributor to the global infectious disease burden and a common cause of hospitalisation for children under 2 years. We compared clinical severity in children hospitalised with respiratory syncytial virus (RSV), parainfluenza virus (PIV), human metapneumovirus (hMPV) and influenza virus (IFV). Methods We used a probabilistically linked population cohort born in Western Australia between 2010 and 2020 and hospitalised before the age of 2 years. Outcomes compared included length of hospital stay (LOS), admission to intensive care unit (ICU), need for respiratory support (RS), complex hospital course (RS, death, ICU admission or LOS >75th percentile), 7-day and 30-day mortality, hospital-in-the-home care, 30-day all-cause and ALRI-specific readmissions and emergency department presentations 14 days prior to hospitalisation. Logistic regression was used for binary outcomes, and negative binomial regression was used for discrete count variables. Incidence rates, time to RS and time to readmissions were calculated using survival analysis techniques. Results The final cohort included 210 997 hospitalised children under 24 months of age for a total of 315 769 admissions. Infants hospitalised before 6 months had the highest rates for all virus-specific hospitalisations, particularly RSV hospitalisations (50.4 per 1000 child-years (95% CI 48.7 to 52.1)). Infants <6 months had higher odds of an ICU admission (adjusted OR (aOR) 2.39, 95% CI 1.36 to 4.19) and RS (aOR 4.68, 95% CI 2.95 to 7.44) and a complex hospital course (aOR 2.69, 95% CI 2.13 to 3.42) with RSV and four times higher hazards of requiring RS earlier (adjusted HR (aHR) 4.06, 95% CI 2.59 to 6.36). An ALRI-coded 30-day readmission was recorded in 10%-24% of virus-specific hospitalisations. Discussion Young infants have a more severe and complex hospital course with RSV hospitalisation compared with hospitalisation with other respiratory viruses and should be prioritised for prevention measures such as the single-dose monoclonal antibody, nirsevimab. 2024 Journal Article http://hdl.handle.net/20.500.11937/97271 10.1136/bmjresp-2024-002613 eng https://creativecommons.org/licenses/by-nc/4.0/ fulltext
spellingShingle Clinical Epidemiology
Respiratory Infection
Humans
Infant
Respiratory Syncytial Virus Infections
Male
Female
Influenza, Human
Metapneumovirus
Paramyxoviridae Infections
Hospitalization
Severity of Illness Index
Western Australia
Length of Stay
Infant, Newborn
Australia
Child, Preschool
Respiratory Tract Infections
Respirovirus Infections
Humans
Metapneumovirus
Respiratory Tract Infections
Paramyxoviridae Infections
Respirovirus Infections
Respiratory Syncytial Virus Infections
Hospitalization
Length of Stay
Severity of Illness Index
Child, Preschool
Infant
Infant, Newborn
Australia
Western Australia
Female
Male
Influenza, Human
Sarna, Minda
Le, H.
Taye, Belaynew
Glass, K.
Levy, A.
Richmond, P.
Moore, Hannah
Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title_full Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title_fullStr Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title_full_unstemmed Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title_short Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care
title_sort clinical outcomes and severity of laboratory-confirmed rsv compared with influenza, parainfluenza and human metapneumovirus in australian children attending secondary care
topic Clinical Epidemiology
Respiratory Infection
Humans
Infant
Respiratory Syncytial Virus Infections
Male
Female
Influenza, Human
Metapneumovirus
Paramyxoviridae Infections
Hospitalization
Severity of Illness Index
Western Australia
Length of Stay
Infant, Newborn
Australia
Child, Preschool
Respiratory Tract Infections
Respirovirus Infections
Humans
Metapneumovirus
Respiratory Tract Infections
Paramyxoviridae Infections
Respirovirus Infections
Respiratory Syncytial Virus Infections
Hospitalization
Length of Stay
Severity of Illness Index
Child, Preschool
Infant
Infant, Newborn
Australia
Western Australia
Female
Male
Influenza, Human
url http://hdl.handle.net/20.500.11937/97271